Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01350 (
gastrin
)
9,683
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. Pylorus ligation stimulated the acid output in vagally intact rats. The serum
gastrin
concentration and the gastric mucosal histamine content were not affected. The gastric
histidine decarboxylase
activity was initially slightly elevated and then greatly reduced (12-20 hr after ligation).2. Pylorus ligation stimulated the acid output in chronically, but not in acutely, vagotomized rats. Chronic vagotomy raises the serum
gastrin
concentration, the gastric histamine content and
histidine decarboxylase
activity. The serum
gastrin
concentration was further raised by pylorus ligation. The histamine content was initially lowered but returned to preligation values after 20 hr. The
histidine decarboxylase
activity first decreased, but increased to very high levels 5-6 hr after ligation. Twelve hours after ligation it was lower than before ligation.3. Following pylorus ligation pentagastrin and histamine stimulated the acid output in vagally intact and in acutely vagotomized but not in chronically vagotomized rats. By contrast, pentagastrin raised the
histidine decarboxylase
activity in vagally intact and in chronically vagotomized, but not in acutely vagotomized rats.4. The two major populations of endocrine cells of the oxyntic gland area (ECL cells and A-like cells) are argyrophil, store histamine and are capable of taking up exogenous DOPA and of decarboxylating it to dopamine which is retained in the cytoplasm for several hours. As evidenced by light and fluorescence microscopy pylorus ligation did not affect their argyrophilia or their ability to produce and store dopamine.5. Pylorus ligation caused ultrastructural changes in the
gastrin
cells of the pyloric gland area and in the histamine-storing ECL and A-like cells of the oxyntic gland area. The two endocrine cell types in the oxyntic gland area were enlarged by pylorus ligation, more so after 16 hr than after 4 hr. The size of the
gastrin
cells seemed unaffected. In all three cell types pylorus ligation reduced the number of cytoplasmic granules. There was no increase in the Golgi area or in the endoplasmic reticulum in any of the endocrine cell types of the oxyntic gland area. It appears unlikely that the ultrastructural changes of the ECL and A-like cells reflect an increased rate of histamine mobilization.6. The acid response to pylorus ligation probably reflects neuronal reflex mechanisms exclusively. There is no evidence that
gastrin
or histamine released from gastric endocrine cells mediate the response.
...
PMID:Gastric acid response to pylorus ligation in rats: is gastrin or histamine involved? 709 72
Fasted rats have a low gastric
histidine decarboxylase
activity. I.v. infusion of heptadecapeptide
gastrin
for 2 h raised the enzyme activity. Intragastric perfusion with the same dose of
gastrin
and for the same period of time did not reproduce the effect of circulating
gastrin
. It is concluded that luminal
gastrin
, in contrast to circulating
gastrin
, does not activate rat stomach
histidine decarboxylase
.
...
PMID:Luminal gastrin does not activate rat stomach histidine decarboxylase. 725 Mar 17
1. The
gastrin
concentrations in serum were elevated after nephrectomy in rats and mice indicating the importance of the kidney for elimination of
gastrin
in these species. In guinea-pigs and rabbits nephrectomy did not cause increased serum
gastrin
concentrations. In rats there was a gradual rise in the serum
gastrin
level up to 48 hr after bilateral nephrectomy and also after ureteral ligation. After the latter operation the concentrations of
gastrin
in serum were lower than after nephrectomy. Significant elevation of the
gastrin
level 48 hr after ureteral ligation indicates that
gastrin
is eliminated at least partly through glomerular filtration. The gastric
histidine decarboxylase
activity after nephrectomy or ureteral ligation generally reflected the concentration of circulating
gastrin
.2. After bilateral ureteral ligation gastric acid secretion in conscious fistula rats was uniformly inhibited with no response to pentagastrin or histamine 24 or 48 hr after the operation. After nephrectomy basal acid secretion was reduced and there was no response to pentagastrin. The response to histamine was still present, although reduced at all dose levels. Linear transformation of the dose-response curve indicated mixed inhibition. The incidence of gastric ulcer was 75% 48 hr after nephrectomy and 30% after ureteral ligation. Since basal and pentagastrin-stimulated acid secretion were unaffected by nephrectomy in rats with the upper two-thirds of the intestine removed, the intestine appears to produce factors which are responsible for the inhibition of gastric secretion.2. On the whole, the
gastrin
concentration in serum and gastric
histidine decarboxylase
activity were not increased after five-sixths nephrectomy. Gastric ulcers were seen in the rats with the highest serum urea levels; one in addition had high serum
gastrin
concentration and gastric
histidine decarboxylase
activity. Basal, pentagastrin- and histamine-stimulated acid secretion were not affected by subtotal nephrectomy. It appears that in the rat about one sixth of the renal mass is the minimum required for handling
gastrin
degradation and excretion.
...
PMID:Importance of the kidneys for gastrin elimination and gastric function. 738 64
The enterochromaffin-like (ECL) cells, which are the predominant endocrine cell type in the acid-producing part of the vertebrate stomach, are characterized by numerous, electron-lucent vesicles and few electron-dense granules in the cytoplasm. The biological and physiological significance of the ECL cells remains poorly understood. They produce and store histamine and pancreastatin and are thought to produce an as yet unidentified peptide hormone. The most important clue to their function is their willingness to respond to changes in circulating
gastrin
. The present review presents current knowledge of the biology and physiology of the rat stomach ECL cells. Examination of serially sectioned ECL cells has revealed that the cytoplasmic vesicles almost invariably contain an electron-dense core, suggesting that perhaps the distinction between granules and vesicles is artificial. We propose a life cycle of the secretory organelles in the ECL cells with a progressive development from granules to vesicles. The results showed that the
gastrin
-evoked release of histamine and pancreastatin was accompanied by loss of vesicles, and that synthesis of histamine and pancreastatin was accelerated by sustained infusion of
gastrin
, a treatment that was associated with renewal of vesicles. The events described are instrumental in bringing about a change in the "steady state" or "equilibrium" of the ECL cells, from a non-stimulated, resting state to a
gastrin
-stimulated, active state. This change is attained within six to eight hr. The next "steady state" change is that from "normal-sized" but active ECL cells to "hypertrophic" ECL cells. The increase in cell size is complete after about one week. The
gastrin
-evoked increase in the ECL cell self-replication rate is maximal after about 10 days, after which time there is a gradual return back to pre-stimulation values. The ECL cell density increases fairly slowly and does not reach maximum (four-fold increase) until after 20 weeks hypergastrinemia. The activity of the histamine-forming enzyme,
histidine decarboxylase
, is elevated by
gastrin
and remains elevated for as long as the
gastrin
stimulus is maintained (the longest time studied was 20 weeks). The physiological significance of the ECL cells is probably related to their capacity to produce and store histamine and an as yet unidentified peptide hormone. The ECL cells are thought to be the source of histamine necessary for the
gastrin
-evoked acid response. In addition, preliminary evidence suggests that the ECL cells and the anticipated ECL cell hormone play a role in bone formation.
...
PMID:The biology and physiology of the ECL cell. 750 21
Somatostatin is a potent inhibitor of gastric acid secretion. However, the effect of somatostatin on gastric histamine secretion and synthesis has not been well understood, despite the fact that histamine plays a key role in the regulation of gastric acid secretion. This study was designed to determine the effect of somatostatin on gastric histamine mobilization and acid secretion in conscious rats. In conscious rats with a gastric fistula, a 4 h intravenous infusion of
gastrin
-17 I (1 nmol/kg/h) evoked a marked increase in fundic
histidine decarboxylase
activity (the sole histamine-forming enzyme) and reduced fundic histamine content with a concomitant increase in gastric acid secretion. Somatostatin-14 (10 nmol/kg/h) significantly inhibited
gastrin
-induced gastric acid secretion and fundic
histidine decarboxylase
activity and prevented a
gastrin
-induced decrease in fundic histamine content. In conscious rats with a vesical fistula, somatostatin-14 (10 nmol/kg/h) significantly inhibited the urinary histamine excretion induced by a
gastrin
-17 I (1 nmol/kg/h) infusion. These findings suggest that the inhibitory action of somatostatin on
gastrin
-induced acid secretion is mediated by the inhibition of histamine mobilization.
...
PMID:Somatostatin inhibits gastrin-induced histamine secretion and synthesis in the rat. 750 34
In a population of rabbit fundic mucosal cells enriched in mucous and endocrine cells,
gastrin
and cholecystokinin octapeptide (CCK-8) were shown to increase dose-dependently
histidine decarboxylase
(
HDC
) activity with the same efficacy and high potencies [50% effective concentration (EC50) 0.389 +/- 0.041 and 0.275 +/- 0.011 nM, respectively], whereas pentagastrin was less potent (EC50 2.90 +/- 0.13 nM). L-365,260 and PD-135,666 inhibited
gastrin
- and CCK-8-stimulated
HDC
activity with a high potency [50% inhibitory concentration (IC50) 1.00 +/- 0.08 and 4.2 +/- 0.7 nM for
gastrin
-stimulated and 1.95 +/- 0.21 and 1.78 +/- 0.12 nM for CCK-8-stimulated
HDC
activity, respectively], whereas L-364,718 was 50 to 100 times less potent (EC50 100 +/- 2.5 and 91.2 +/- 3.1 nM, respectively on
gastrin
- and CCK-8-stimulated
HDC
activity). Carbachol also dose-dependently increased
HDC
activity (EC50 7.08 +/- 0.32 nM), and its effect was reversed by selective muscarinic-receptor antagonists with the following order of potency: pirenzepine (IC50 15.1 +/- 1.2 nM) > para-fluoro-hexahydro-siladifenidol (IC50 0.316 +/- 0.02 microM) > 11-2[(2-[(diethyl-amino)-methyl]-1-piperidinyl)acetyl]-5,11-dihydro-6H- pyrido[2,3-b][1,4]benzodiazepine-6-one (IC50 28.5 +/- 1.1 microM). Moreover,
gastrin
and carbachol were able to modify slightly but significantly both the Michaelis constant (Km) and the maximal velocity (Vmax) of
HDC
in the same way (18-20% reduction of the Km and 25-30% increase of the Vmax).(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Neurohormonal regulation of histamine synthesis in isolated rabbit fundic mucosal cells. 751 26
The hormone
gastrin
stimulates acid secretion by releasing histamine from gastric enterochromaffin-like (ECL) cells and induces ECL cell proliferation in vivo. This study uses a > 90% pure ECL cell preparation in culture to compare
gastrin
effects on histamine release,
histidine decarboxylase
(
HDC
) activity, and DNA synthesis.
Gastrin
and the cholecystokinin octapeptide (CCK-8, nonsulfated) induced histamine release from ECL cells (24-96 h of primary culture) within 5 min of incubation [concentration eliciting 50% of maximal response (EC50), 4 and 2 x 10(-11) M, respectively]. The CCK-B antagonist L-365,260 inhibited this effect [concentration inhibiting 50% of maximal response (IC50), 2 x 10(-8) M], whereas the CCK-A antagonist L-364,718 (10(-8) M) and the tyrosine kinase inhibitor genistein (10(-4) M) had no effect. Histamine release was associated with a biphasic elevation of intracellular Ca2+.
Gastrin
stimulated
HDC
activity two- to threefold after 60 min of incubation (EC50, 10(-10) M).
Gastrin
also increased DNA synthesis in ECL cells, with an EC50 of 1.7 x 10(-12) M as measured by the incorporation of 5-bromo-2'-deoxyuridine (BrdU). Positive nuclear immunostaining increased two- to threefold in up to 20% of ECL cells after 48-96 h of incubation. This effect was inhibited by L-365,260 (IC50, 5 x 10(-9) M) and by genistein (10(-4) M) but was not altered by L-364,718 (10(-8) M). The antisecretory drugs omeprazole, lansoprazole, and pantoprazole did not affect BrdU incorporation in isolated ECL cells. In conclusion, acute and chronic
gastrin
effects on the ECL cell are mediated via CCK-B receptors but differ in apparent receptor affinity and signal transduction pathways.
...
PMID:Gastrin effects on isolated rat enterochromaffin-like cells in primary culture. 752 50
The effect of octreotide, a potent and long-acting analogue of somatostatin, on
gastrin
-stimulated proliferation and function of enterochromaffin-like (ECL) cells were examined in rats. Animals were divided into four groups and each group was continuously infused with saline, octreotide alone (40 micrograms/kg per day),
gastrin
alone (60 nmol/kg per day), or octreotide (40 micrograms/kg per day) plus
gastrin
(60 nmol/kg per day) respectively for 9 days via osmotic minipumps.
Gastrin
induced the increase of the bromodeoxyuridine labeling index and density of oxyntic mucosal ECL cells as well as oxyntic mucosal
histidine decarboxylase
activity. Octreotide completely abolished the
gastrin
-induced increases in the labeling index and density of ECL cells and oxyntic mucosal
histidine decarboxylase
activity. These results indicate that octreotide inhibits
gastrin
-stimulated proliferation of ECL cells and histamine production by these cells.
...
PMID:Inhibition of gastrin-stimulated enterochromaffin-like cell proliferation and mucosal histamine production in the rat stomach by the somatostatin analogue octreotide. 754 3
Smoking has an unfavourable effect on peptic ulcer disease. The pathophysiological mechanisms underlying this effect are not known. The enterochromaffin like (ECL) cell is the cellular source of histamine participating in the regulation of acid secretion. The ECL cell is under functional and trophic control of
gastrin
and the vagus nerves. Nicotine may affect acid secretion through vagal pathways. Furthermore, nicotine may also stimulate neuroendocrine cells. The present study examined if chronic nicotine administration could stimulate the function and growth of the ECL cell. Rats inhaled nicotine vapour at a concentration of approximately 6.2 mumol/m3, 20 hours/day, 5 days/week for 11 weeks. Steady state plasma nicotine concentration was 461.8 (137.5 (SD)) nmol/l. The ECL cell density, histamine content and
histidine decarboxylase
activity of the oxynitic mucosa were similar to the controls. We also examined the effect of acute nicotine stimulation on the acid output and histamine release from the totally isolated vascularly perfused rat stomach. Nicotine did not stimulate acid secretion or histamine release. Thus no evidence could be provided to support the hypothesis that nicotine exerts its negative effects on peptic ulcer disease by stimulating the ECL cell.
...
PMID:Effect of nicotine on the enterochromaffin like cells of the oxyntic mucosa of the rat. 768 47
During recent years, the so-called ECL cells of the acid-producing part of the stomach have attracted much attention, mainly due to the fact that mice and rats were found to develop gastric carcinoids (ECL cell tumors) following life-long treatment with blockers of acid secretion. These observations touched off concern about the safety of the long-term clinical use of such drugs. The ECL cells are the predominant endocrine cell population in the oxyntic mucosa. They produce histamine, chromogranin A/pancreastatin and an as yet unidentified peptide hormone. They respond to
gastrin
by the release of secretory products; more long-term responses include adaptation to the
gastrin
stimulus, hypertrophy and hyperplasia. Intravenous infusion of maximally effective doses of
gastrin
promptly reduced the number of cytoplasmic vesicles in the ECL cells and their content of histamine and pancreastatin. Despite the ongoing infusion of
gastrin
, the number of vesicles and the content of histamine and pancreastatin were back to normal 4-6 h after the start of the infusion. The
histidine decarboxylase
(
HDC
) activity and
HDC
mRNA level increased progressively until plateaus were reached after 6-8 h of
gastrin
infusion. The size of the ECL cells started to increase about 4 days after the start of a subcutaneous
gastrin
infusion (resulting in half-maximally effective serum
gastrin
concentrations). The ECL cell size reached maximum after about 2 weeks and then remained at this level.The number of cytoplasmic vesicles was increased; this effect seemed to reach a maximum after 1-2 weeks.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:ECL cells: biology and pathobiology. 769 36
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>